Rufinamide

Trade Name: 
Banzel
Manufacturer/Distributor: 
Eisai Limited
1-877-873-4724
Classification: 
Antiepileptic
ATC Class: 
N03AF03 - Rufinamide
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2011/06/22
Date Marketed in Canada (yyyy/mm/dd): 
2011/09
Presentation: 
Tablet, 100 mg. DIN: 02369613
Tablet, 200 mg. DIN: 02369321
Tablet, 400 mg. DIN: 02369648
Comments: 
For the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children aged 4 years and older and adults.